Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Compounds And Method
    1.
    发明申请
    Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Compounds And Method 失效
    异恶唑,二氢异恶唑和恶二唑取代的咪唑环化合物及方法

    公开(公告)号:US20070287725A1

    公开(公告)日:2007-12-13

    申请号:US11570716

    申请日:2005-06-17

    CPC分类号: C07D471/04 C07D471/14

    摘要: Imidazo ring compounds, (e.g. imidazo[4,5-c]pyridine, imidazo[4,5-c]quinoline, 6,7,8,9-tetrahydro imidazo[4,5-c]quinoline, and imidazo[4,5-c]naphthyridine compounds) having an isoxazole, dihydroisoxazole, or oxadiazole substituent at the 1-position, pharmaceutical compositions containing the compounds, intermediates, and methods of making and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

    摘要翻译: 咪唑环化合物(例如咪唑并[4,5-c]吡啶,咪唑并[4,5-c]喹啉,6,7,8,9-四氢咪唑并[4,5-c]喹啉和咪唑并[ 在1位具有异恶唑,二氢异恶唑或恶二唑取代基的5-c]萘啶化合物,含有化合物的药物组合物,中间体及其制备方法以及这些化合物作为免疫调节剂的用途,用于调节动物中的细胞因子生物合成 并且公开了治疗包括病毒和肿瘤疾病在内的疾病。

    Sulfone substituted imidazo ring ethers
    6.
    发明申请
    Sulfone substituted imidazo ring ethers 失效
    砜取代的咪唑环醚

    公开(公告)号:US20070155767A1

    公开(公告)日:2007-07-05

    申请号:US10596117

    申请日:2004-12-03

    IPC分类号: A61K31/4745 C07D471/14

    CPC分类号: C07D471/04 C07D471/14

    摘要: Imidazo ring compounds (e.g., imidazoquinolines, 6,7,8,9-tetrahydroimidazoquinolines, imidazonaphthyridines, and 6,7,8,9-tetrahydroimidazonaphthyridines) with a sulfide-, sulfinyl-, or sulfonyl-containing ether substituent at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

    摘要翻译: 咪唑环化合物(例如,咪唑并喹啉,6,7,8,9-四氢咪唑并喹啉,咪唑并吡啶和6,7,8,9-四氢咪唑并萘啶)与1-位硫醚基,亚磺酰基或磺酰基醚取代基 公开了含有化合物的药物组合物,中间体,制备该化合物的方法,以及这些化合物作为免疫调节剂的用途,用于诱导动物中的细胞因子生物合成和治疗包括病毒和肿瘤疾病在内的疾病。